These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 29786075)
1. TP53 gain-of-function mutation promotes inflammation in glioblastoma. Ham SW; Jeon HY; Jin X; Kim EJ; Kim JK; Shin YJ; Lee Y; Kim SH; Lee SY; Seo S; Park MG; Kim HM; Nam DH; Kim H Cell Death Differ; 2019 Mar; 26(3):409-425. PubMed ID: 29786075 [TBL] [Abstract][Full Text] [Related]
2. Biallelic TP53 gain of function mutations in rapidly progressing solid tumors. Sande CM; Chang B; Monga V; Bossler AD; Ma D Cancer Genet; 2018 Apr; 222-223():20-24. PubMed ID: 29666004 [TBL] [Abstract][Full Text] [Related]
3. Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development. Kazantseva M; Eiholzer RA; Mehta S; Taha A; Bowie S; Roth I; Zhou J; Joruiz SM; Royds JA; Hung NA; Slatter TL; Braithwaite AW J Pathol; 2018 Sep; 246(1):77-88. PubMed ID: 29888503 [TBL] [Abstract][Full Text] [Related]
4. The role of TP53 gain-of-function mutation in multifocal glioblastoma. Olafson LR; Gunawardena M; Nixdorf S; McDonald KL; Rapkins RW J Neurooncol; 2020 Mar; 147(1):37-47. PubMed ID: 32002804 [TBL] [Abstract][Full Text] [Related]
5. A new method of identifying glioblastoma subtypes and creation of corresponding animal models. Zhou X; Li G; An S; Li WX; Yang H; Guo Y; Dai Z; Dai S; Zheng J; Huang J; Iavarone A; Zhao X Oncogene; 2018 Aug; 37(35):4781-4791. PubMed ID: 29769617 [TBL] [Abstract][Full Text] [Related]
6. Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties. Nakayama M; Hong CP; Oshima H; Sakai E; Kim SJ; Oshima M Nat Commun; 2020 May; 11(1):2333. PubMed ID: 32393735 [TBL] [Abstract][Full Text] [Related]
7. Sex- and mutation-specific p53 gain-of-function activity in gliomagenesis. Rockwell NC; Yang W; Warrington NM; Staller MV; Griffith M; Griffith OL; Gurnett CA; Cohen BA; Baldridge D; Rubin JB Cancer Res Commun; 2021 Dec; 1(3):148-163. PubMed ID: 34957471 [TBL] [Abstract][Full Text] [Related]
8. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1. Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868 [TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of an immune-based prognostic score model in glioblastoma. Qin Z; Zhang X; Chen Z; Liu N Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425 [TBL] [Abstract][Full Text] [Related]
10. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma. Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422 [TBL] [Abstract][Full Text] [Related]
12. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956 [TBL] [Abstract][Full Text] [Related]
13. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071 [TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368 [TBL] [Abstract][Full Text] [Related]
15. Gain of function of mutant TP53 in glioblastoma: prognosis and response to temozolomide. Wang X; Chen JX; Liu JP; You C; Liu YH; Mao Q Ann Surg Oncol; 2014 Apr; 21(4):1337-44. PubMed ID: 24248532 [TBL] [Abstract][Full Text] [Related]
16. Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors. Wang D; Nakayama M; Hong CP; Oshima H; Oshima M Cancer Res; 2024 Jan; 84(1):56-68. PubMed ID: 37851521 [TBL] [Abstract][Full Text] [Related]
17. Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations. Meng X; Yang S; Li Y; Li Y; Devor EJ; Bi J; Wang X; Umesalma S; Quelle DE; Thiel WH; Thiel KW; Leslie KK Dis Markers; 2018; 2018():3810108. PubMed ID: 30647797 [TBL] [Abstract][Full Text] [Related]
18. Ionizing radiation-induced gene expression changes in TP53 proficient and deficient glioblastoma cell lines. Godoy PR; Mello SS; Magalhães DA; Donaires FS; Nicolucci P; Donadi EA; Passos GA; Sakamoto-Hojo ET Mutat Res; 2013 Aug; 756(1-2):46-55. PubMed ID: 23817105 [TBL] [Abstract][Full Text] [Related]
19. A syngeneic spontaneous zebrafish model of Weiss A; D'Amata C; Pearson BJ; Hayes MN Elife; 2024 Jul; 13():. PubMed ID: 39052000 [TBL] [Abstract][Full Text] [Related]
20. MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia. Jung Y; Ahn SH; Park H; Park SH; Choi K; Choi C; Kang JL; Choi YH Cell Physiol Biochem; 2018; 48(3):1332-1346. PubMed ID: 30048972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]